Colon Cancer: Symptoms, Stages, Screening, and Treatment

Colon cancer ranks as the fourth deadliest cancer in the world, accounting for 10% of all cancer cases and 9.4% of cancer-related deaths globally. Despite these statistics, colon cancer is also one of the most preventable and treatable malignancies, when detected early. In 2020, colorectal cancer resulted in over 900,000 deaths globally, with 419,536 deaths among women and 515,637 among men. The disease affects both sexes across all populations, though incidence patterns vary by geography, age, and lifestyle factors.

What Is Colon Cancer?

Colon cancer is a malignant neoplasm that originates in the epithelial cells lining the inner wall of the colon – the longest portion of the large intestine. The colon, approximately 5 feet in length, works alongside the rectum (the final 6 inches of the large intestine) to absorb water and electrolytes from digested food and eliminate waste . Cancer that starts in the colon is called colon cancer; when it starts in the rectum, it is called rectal cancer. Together, these are often referred to as colorectal cancer (CRC).

The Adenoma-Carcinoma Sequence

Most colon cancers do not appear suddenly. Instead, they develop through a well-characterized progression known as the adenoma-carcinoma sequence. This process typically unfolds over 5 to 10 years or longer.

The progression follows these steps:

1. Normal mucosa – Healthy colon lining
2. Small polyp (adenoma) – A benign, abnormal growth
3. Large or dysplastic polyp – Cells begin to show abnormal features
4. Carcinoma in situ – Cancer cells confined to the polyp
5. Invasive cancer – Cancer penetrates deeper layers of the colon wall

Most colorectal cancers start in adenomatous polyps. While most polyps are harmless and will never become cancerous, removing polyps during screening colonoscopy prevents them from ever progressing to cancer.

Influenza (Flu): Symptoms, Causes, and Treatment Options

The rarer diseases of the small intestine are not considered colorectal cancer. Additionally, cancers such as gastrointestinal stromal tumors (GIST), MALT-lymphoma, and neuroendocrine tumors can develop in the intestines but are classified separately from colorectal carcinoma .

TYPES AND CLASSIFICATIONS

More than 95% of colorectal cancers are adenocarcinomas, which arise from the glandular cells that line the inside of the colon and rectum. These are the focus of this article.

Less common types include:

1. Carcinoid tumors – Arising from hormone-producing cells
2. Gastrointestinal stromal tumors (GISTs) – Arising from interstitial cells of Cajal
3. Lymphomas – Arising from immune system cells
4. Sarcomas – Arising from connective tissue

Anatomic Location

Colon cancers are further classified by their location within the large intestine:

1. Right-sided colon cancer – Cecum, ascending colon, hepatic flexure
2. Transverse colon cancer
3. Left-sided colon cancer – Splenic flexure, descending colon
4. Sigmoid colon cancer – Most common location
5. Rectal cancer – Distinct management considerations

The distinction between right-sided and left-sided cancers has prognostic and therapeutic implications, as they respond differently to certain targeted therapies.

CAUSES AND RISK FACTORS

Colorectal cancer arises from a complex interplay of genetic predisposition, environmental exposures, and lifestyle factors.

Non-Modifiable Risk Factors

Risk Factor	Impact
Age	Risk increases after age 50; most cases diagnosed after age 50
Family history	Having a first-degree relative with CRC doubles personal risk
Inherited genetic syndromes	Lynch syndrome (HNPCC), Familial Adenomatous Polyposis (FAP)
Personal history	Previous CRC or high-risk adenomas (polyps ≥1 cm)
Inflammatory bowel disease	Crohn’s disease and ulcerative colitis increase risk
Race	Black individuals have higher incidence and mortality rates

 Testosterone and Hormones: Optimization of Low Testosterone with Natural Remedy and Supplementation

Modifiable Risk Factors (Lifestyle and Diet)

Tobacco smoking is strongly linked to CRC risk. Carcinogens in cigarette smoke, including aromatic amines, polycyclic aromatic hydrocarbons, and nitrosamines, contribute to cancer formation. Smoking is associated with genetic alterations typical in CRC, including p53 mutations, APC mutations, and microsatellite instability.

Alcohol consumption of three or more alcoholic beverages per day increases CRC risk. Alcohol is also linked to the formation of large colorectal adenoma.

Dietary factors play a substantial role:

1. High red and processed meat intake – Consuming over 100 grams of red meat daily is associated with a 98% increase in colorectal adenoma risk
2. High-fat diets – Stimulate gut microorganisms to produce secondary bile acids, creating a pro-cancer environment with chronic inflammation
3. Excessive iron intake – More than 18 mg/day of iron supplements may activate pro-cancer pathways including WNT signaling, AKT, MAPK, and EGFR
4. Sugary beverages and foods – Frequent consumption raises blood glucose, leading to hyperinsulinemia and increased cancer risk through AKT and MAPK pathways

Obesity and physical inactivity are established risk factors. Excess belly fat is associated with greater CRC risk before age 50, as it leads to insulin resistance, chronic inflammation, and alterations in growth-regulating hormones. A sedentary lifestyle increases risk, while regular physical activity is protective.

Protective Factors

Several factors have been shown to decrease CRC risk:

1. Regular physical activity – A lifestyle that includes regular exercise is linked to decreased risk
2. Dietary fiber – High-fiber intake increases stool bulk, reduces colon transit time, and enhances fermentation producing short-chain fatty acids that lower intestinal carcinogen levels . Eating 90 grams of whole grains daily reduces CRC risk by 17%
3. Aspirin – Daily aspirin for at least two years lowers CRC risk and mortality, though benefits begin 10-20 years after initiation
4. Dairy products – Calcium and vitamin D from dairy may be protective
5. Fruits, vegetables, and green tea – Rich in antioxidants and protective compounds

The National Cancer Institute notes that combination hormone replacement therapy (estrogen plus progestin) lowers the risk of invasive CRC in postmenopausal women, though women who develop CRC on HRT tend to be diagnosed at more advanced stages.

Signs and Symptoms: Recognizing the Warning Signs

One of the most challenging aspects of colon cancer is its asymptomatic presentation in early stages. Precancerous polyps and even some early-stage cancers cause no symptoms at all, which is why routine screening beginning at age 45 is so critical .

Erectile Dysfunction: Causes, Symptoms, Diagnosis & Treatment Options

Symptoms That May Indicate Colon Cancer

When symptoms do appear, they may include:

Changes in bowel habits:

1. Persistent diarrhea or constipation
2. Alternating episodes of diarrhea and constipation
3. Feeling that the bowel does not empty completely (tenesmus)
4. Increased stool urgency

Abnormal stool characteristics:

1. Blood in the stool (bright red or dark/black, indicating digested blood)
2. Narrow or “pencil-thin” stool
3. Mucus in the stool
4. Particularly foul-smelling stool

Abdominal symptoms:

1. Persistent abdominal pain or cramping, sometimes continuing after bowel movements
2. Bloating, frequent loud intestinal noises
3. Feeling of fullness despite eating little
4. Nausea

Systemic symptoms:

1. Unexplained weight loss
2. Fatigue and weakness (often from iron-deficiency anemia caused by chronic occult bleeding)
3. Unexplained anemia detected on blood tests

While many of these symptoms can also indicate benign conditions such as hemorrhoids, irritable bowel syndrome, or diverticulosis, they warrant medical evaluation, particularly if they persist for more than a few weeks or if typical risk factors are present.

COLON CANCER SCREENING

Screening for colon cancer stands apart from screening for most other cancers because it is the most powerful tool that can prevent the cancer, not just detect it early. By identifying and removing precancerous polyps during colonoscopy, screening interrupts the adenoma-carcinoma sequence before invasive cancer develops.

Screening Guidelines

The American College of Gastroenterology recommends CRC screening for individuals aged 50–75, with the possibility of initiating at 45. The Centers for Disease Control and Prevention (CDC) recommends that adults at average risk begin regular screening at age 45.

For individuals over 75, screening decisions should be individualized based on risks and life expectancy, as older adults face higher chances of adverse outcomes such as bowel perforation, false positives, and dehydration from bowel preparation . Routine screening is generally not recommended after age 85.

For those with a family history, screening should begin at age 40 or 10 years prior to the youngest affected family member if there is a first-degree relative with CRC or advanced polyps before age 60, or two first-degree relatives diagnosed after age 60. Family history affects approximately 10% of people and at least doubles CRC risk.

Screening Tests

Colonoscopy is the gold standard and most common screening test. It is the only test that can both detect and remove polyps during the same procedure. A flexible tube with a camera is inserted through the anus, allowing examination of the entire colon (all 5 feet). If normal, the procedure is typically repeated every 10 years .

Flexible sigmoidoscopy uses a shorter tube to examine only the lower part of the colon. While it can also remove polyps, it does not visualize the entire colon. Bowel preparation is simpler (an enema rather than full cleansing), and anesthesia is usually not required .

Stool-based Tests offer non-invasive alternatives such as:

• Fecal Immunochemical Test (FIT) – Detects hidden blood in the stool; recommended annually
• High-sensitivity guaiac fecal occult blood test (gFOBT) – Another blood detection test
• Stool DNA test (sDNA-FIT) – The only FDA-approved stool DNA test, which looks for DNA biomarkers shed from colon and rectal lining cells

If any stool-based test returns abnormal results, a follow-up colonoscopy is required for definitive evaluation.

Esophageal Cancer: Symptoms, Causes, Diagnosis, and Treatment

Virtual colonoscopy (CT colonography) uses CT scan technology to create 2D and 3D images of the colon and rectum. However, if polyps are found, a standard colonoscopy is still needed for removal.

According to MSK experts, “The best test for colorectal screening is the one that gets done, and done well. Colonoscopy is the preferred method because it prevents cancer by snipping out polyps before they grow into cancer”.

COLON CANCER STAGING: UNDERSTANDING THE EXTENT OF DISEASE

Once colon cancer is diagnosed, accurate staging determines prognosis and guides treatment decisions. The TNM staging system developed by the American Joint Committee on Cancer is the standard for colorectal disease .

Components of TNM Staging

Component	Definition
T (Tumor)	Depth of tumor invasion through the bowel wall
N (Nodes)	Number and location of lymph nodes containing cancer
M (Metastasis)	Presence or absence of spread to distant organs

 

Stage Groupings Summary

• Stage 0 – Carcinoma in situ (cancer confined to the innermost lining)
• Stage I – Tumor invades submucosa or muscularis propria but not beyond; no lymph node involvement
• Stage II – Tumor extends through muscularis propria or into adjacent structures; no lymph node involvement
• Stage III – Any tumor depth with regional lymph node involvement; no distant metastases
• Stage IV – Distant metastases present (most commonly to liver or lungs)

Five-year survival rates decline dramatically with advancing stage:

• Localized (Stage I-II) – 90% or higher
• Regional (Stage III) – Approximately 70-75%
• Distant (Stage IV) – Approximately 15-20%

DIAGNOSIS FOR COLON CANCER

Initial Evaluation: When colon cancer is suspected based on symptoms or abnormal screening results, the diagnostic pathway includes:

1. Colonoscopy with biopsy – The diagnostic gold standard. The gastroenterologist visualizes the suspicious area and removes tissue samples for histopathologic examination. India ink tattoos or metallic clips may be placed to mark the tumor location for future surgery .
2. Pathologic examination – Confirms diagnosis, determines histologic type (adenocarcinoma vs. others), identifies tumor grade (well, moderate, or poorly differentiated), and tests for molecular markers (RAS, BRAF, MSI status, HER2, PD-L1).

Staging Workup: Once cancer is confirmed, staging studies are performed:

1. CT scan of chest, abdomen, and pelvis – Assesses extent of local disease and identifies distant metastases (particularly liver and lung)
2. Chest X-ray – Alternative for lung evaluation
3. Blood tests – Complete blood count (for anemia), liver function tests (for hepatic metastases), carcinoembryonic antigen (CEA) level (tumor marker for monitoring)
4. MRI of the pelvis – For rectal cancer specifically, to assess depth of penetration into the mesorectum
5. PET-CT – In select cases to identify occult metastases

Stroke: Causes, Symptoms, Diagnosis, and Treatment Options

TREATMENT OPTIONS FOR COLON CANCER

Treatment of colon cancer has evolved significantly, with approaches tailored to stage, tumor biology, patient performance status, and treatment goals.

Stage 0 and Stage I (Early, Localized Disease)

For early cancers confined to the innermost layers of the colon wall:

• Endoscopic resection – Polypectomy or endoscopic mucosal resection (EMR) may be curative without surgery
• Local excision – For appropriately selected small tumors

No additional chemotherapy or radiation is required for completely resected Stage I cancers.

Stage II and Stage III (Locally Advanced, Node-Positive)

Surgery is the primary treatment for resectable colon cancer:

• Partial colectomy (segmentectomy) – Removal of the tumor-bearing segment of colon along with surrounding lymph nodes, followed by reconnection (anastomosis) of the healthy ends
• Laparoscopic (minimally invasive) colectomy – When feasible, offers faster recovery and reduced pain

Adjuvant chemotherapy is recommended for:

• All Stage III patients (lymph node-positive disease)
• High-risk Stage II patients (T4 tumors, inadequate lymph node sampling, bowel perforation, poorly differentiated histology)

Standard adjuvant regimens include FOLFOX (5-FU, leucovorin, oxaliplatin) or CAPOX (capecitabine plus oxaliplatin), typically administered for 3 to 6 months.

Important development: According to a 2025 review, systemic treatments such as chemotherapy, targeted therapy, and immunotherapy are used for Stages II, III, and IV as clinically indicated .

Stage IV (Metastatic Disease)

When colon cancer has spread to distant organs (most commonly liver, lungs, or peritoneum), treatment goals shift toward prolonging survival, controlling symptoms, and maintaining quality of life:

• Systemic therapy – Chemotherapy (FOLFOX, FOLFIRI, FOLFOXIRI) combined with biologic agents
• Targeted therapy – For tumors with specific mutations: anti-EGFR agents (cetuximab, panitumumab) for RAS wild-type tumors; anti-VEGF agents (bevacizumab) for all patients
• Immunotherapy – PD-1 inhibitors (pembrolizumab, nivolumab) for tumors with MSI-H (microsatellite instability-high) or dMMR (mismatch repair deficiency)
• Metastasectomy – Surgical removal of isolated liver or lung metastases in select patients offers potential for long-term survival
• Ablative therapies – Radiofrequency ablation (RFA) or microwave ablation for small liver metastases
• Palliative interventions – For patients not candidates for curative-intent therapy

Immune Boosters for Kids: Foods, Habits & Supplements That Actually Work

Emerging and Neoadjuvant Approaches

For patients with locally advanced rectal cancer (a related but distinct entity from colon cancer), neoadjuvant chemoradiotherapy (chemotherapy plus radiation before surgery) is standard to shrink the tumor, increase the likelihood of complete resection, and improve sphincter preservation.

Current clinical trials are investigating the role of neoadjuvant immunotherapy for dMMR colon cancers, with some patients achieving complete pathologic responses without surgery—a paradigm-shifting development.

COMPLICATIONS OF COLON CANCER AND ITS TREATMENT

Disease-Related Complications

• Bowel obstruction – Tumor can physically block the colon, causing abdominal distension, vomiting, and inability to pass stool. This often requires emergency surgery.
• Bowel perforation – Tumor erodes through the full thickness of the colon wall, leading to peritonitis (abdominal infection), a surgical emergency.
• Severe bleeding – Chronic occult bleeding causes iron-deficiency anemia; acute massive bleeding may require transfusion or urgent intervention.
• Metastatic complications – Liver metastases causing jaundice or ascites; lung metastases causing pleural effusion or dyspnea; bone metastases causing pain or pathologic fractures.

Treatment-Related Complications

• Surgical complications – Anastomotic leak, wound infection, bleeding, ileus (bowel inactivity), adhesive small bowel obstruction
• Chemotherapy toxicities – Fatigue, nausea/vomiting, diarrhea, neuropathy (oxaliplatin), hand-foot syndrome (capecitabine), myelosuppression (low blood counts)
• Radiation toxicities (for rectal cancer) – Proctitis, diarrhea, bladder irritation, sexual dysfunction
• Immunotherapy adverse effects – Colitis, pneumonitis, hepatitis, endocrinopathies (thyroiditis, hypophysitis)

Long-Term Survivorship Issues

Colon cancer survivors require ongoing surveillance for recurrence (typically with periodic CEA testing and colonoscopy) and management of late effects, including bowel dysfunction and psychological distress.

Sepsis: Causes, Symptoms, Diagnosis & Treatment Options

PREVENTION STRATEGIES

Colon cancer is one of the most preventable malignancies through a combination of lifestyle modification and regular screening.

Primary Prevention (Risk Reduction)

Lifestyle measures with strong evidence:

1. Regular screening (age 45 and older, or earlier with family history) – The single most effective prevention strategy
2. Dietary modifications:
   • Increase fiber intake (whole grains, fruits, vegetables, legumes) – 90 grams of whole grains daily reduces risk by 17%
   • Limit red meat (beef, pork, lamb) to less than 500 grams (cooked weight) per week
   • Avoid processed meats (bacon, sausage, ham, hot dogs, deli meats)
   • Consume calcium and vitamin D from dairy or fortified alternatives
3. Maintain healthy body weight – Avoid obesity, particularly abdominal obesity
4. Regular physical activity – At least 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity exercise weekly
5. Avoid tobacco – Smoking cessation reduces risk; the longer since quitting, the lower the risk
6. Limit alcohol – No more than 1 drink daily for women, 2 for men; less is better
7. Consider aspirin – For individuals ages 50-69 with elevated cardiovascular risk and low bleeding risk, low-dose aspirin may be considered after discussing risks and benefits with a physician

Secondary Prevention (Early Detection)

• Adhere to recommended screening intervals based on personal risk
• Do not ignore persistent bowel symptoms, rectal bleeding, or unexplained iron-deficiency anemia
• For individuals with first-degree relatives with CRC, begin screening 10 years before the age of the youngest affected relative

Tertiary Prevention (Preventing Recurrence)

Following curative treatment, patients should:

• Complete recommended adjuvant chemotherapy
• Attend all surveillance appointments (typically CEA testing every 3-6 months for 3 years, then annually; CT scans per risk assessment; colonoscopy at 1 year, then 3 years, then 5 years)
• Maintain healthy lifestyle habits to reduce risk of second primary cancers

Menstrual Disorders: Types, Causes, Symptoms & Treatment Options

LIFESTYLE AND MANAGEMENT TIPS FOR PATIENTS AND SURVIVORS

For individuals diagnosed with colon cancer or those at high risk, proactive management strategies improve outcomes and quality of life.

During Active Treatment

Nutritional support:

• Maintain adequate protein and calorie intake to support healing and immune function
• Work with a registered dietitian, particularly during chemotherapy when taste changes and nausea are common
• Consider small, frequent meals if large meals are poorly tolerated

Managing chemotherapy side effects:

• Peripheral neuropathy (oxaliplatin) – Avoid cold drinks and cold exposure; discuss dose modification with oncologist if severe
• Fatigue – Balance activity with rest; mild exercise may improve energy levels
• Nausea – Take antiemetics as prescribed; avoid strong food odors

Post-Treatment Survivorship

Follow-up schedule (per NCCN guidelines):

• Physical exam every 3-6 months for 3 years, then every 6 months for 2 years, then annually
• CEA blood test at each follow-up visit if candidate for further treatment
• CT scan of chest/abdomen/pelvis annually for 3 years for high-risk patients
• Colonoscopy at 1 year after resection (unless no polyp detected preoperatively, then at 3 years)

Long-term health maintenance:

• Address bowel changes (diarrhea, constipation, urgency) with dietary modifications, fiber supplements, or medications as needed
• Monitor for and manage chemotherapy late effects (neuropathy, fatigue)
• Maintain healthy lifestyle to reduce risk of second cancers and cardiovascular disease
• Attend to mental health; many survivors experience anxiety about recurrence or post-traumatic stress

FREQUENTLY ASKED QUESTIONS (FAQS) ABOUT COLON CANCER

1. At what age should I start getting screened for colon cancer?

Adults at average risk should begin screening at age 45 . If you have a first-degree relative (parent, sibling, child) with colorectal cancer or advanced polyps, you should begin screening at age 40, or 10 years before the age of the youngest affected family member, whichever is earlier . African Americans and individuals with other risk factors may need earlier or more frequent screening; discuss with your healthcare provider.

2. What is the difference between a colonoscopy and a stool test?

A colonoscopy is a procedure in which a flexible tube with a camera is inserted through the anus to examine the entire colon. It is the only test that can both detect AND remove precancerous polyps during the same session. Stool tests (FIT, gFOBT, stool DNA) are non-invasive tests you perform at home that look for hidden blood or DNA markers of cancer. However, if a stool test is positive, you will still need a colonoscopy for follow-up. Colonoscopy remains the gold standard .

Tuberculosis (TB): Symptoms, Diagnosis, and Treatment

3. Can colon cancer be cured?

Yes. When detected at an early stage (Stage I or II), colon cancer has a 5-year survival rate exceeding 90% and is often curable with surgery alone. Even Stage III (lymph node-positive) disease is potentially curable with a combination of surgery and adjuvant chemotherapy. Stage IV (metastatic) disease is generally not curable, but modern treatments—including chemotherapy, targeted therapy, immunotherapy, and surgical removal of isolated metastases—can prolong survival and maintain quality of life, with some patients achieving long-term remission.

4. Does having polyps mean I have colon cancer?

No. Most colon polyps are benign (non-cancerous). However, nearly all colon cancers develop from polyps through the adenoma-carcinoma sequence over many years. This is precisely why screening colonoscopy is so valuable: when a polyp is found and removed, it cannot progress to cancer. The type of polyp matters: adenomatous polyps have the potential to become cancerous, while hyperplastic polyps generally do not. Your pathology report will specify the type and whether any concerning features (dysplasia) are present .

5. Does diet affect colon cancer risk?

Yes, substantially. A high-fiber diet rich in whole grains, fruits, vegetables, and legumes is protective. The World Cancer Research Fund reports that eating 90 grams of whole grains daily reduces colorectal cancer risk by 17% . Conversely, high consumption of red meat (beef, pork, lamb) and processed meats (bacon, sausage, ham, deli meats) increases risk, as do high-fat diets, excessive iron intake, and sugary foods and beverages . Adopting a healthy diet is a key modifiable risk factor.

Congenital Heart Disease: Types, Causes, Symptoms & Treatment Options

What Is Muscular Dystrophy? Causes, Types & Treatment Advancements